GIKLY Stock Grifols Sa (GIKLY, $6.6) RSI Indicator left the overbought zone on January 26, 2026
at Tickeron.com
This is a signal that GIKLY's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. A.I.dvisor looked back and found 31 similar cases where GIKLY's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Odds of Success:
GIKLY sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for GIKLY moved below the 200-day moving average on January 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Bullish Trend Analysis
GIKLY moved above its 50-day moving average on January 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for GIKLY crossed bullishly above the 50-day moving average on January 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.463) is normal, around the industry mean (9.533). P/E Ratio (20.363) is within average values for comparable stocks, (24.433). Projected Growth (PEG Ratio) (0.236) is also within normal values, averaging (1.907). Dividend Yield (0.013) settles around the average of (0.025) among similar stocks. P/S Ratio (1.008) is also within normal values, averaging (3.990).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GIKLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GIKLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
Advertisement
General Information
Industry PharmaceuticalsMajor